COVID-19: CDC, FDA and CMS Guidance
This page includes AHA Today stories and other AHA content on coronavirus COVID-19 guidance from the CDC, FDA, and CMS.
FDA Saturday issued an emergency use authorization to Yale School of Public Health for a new test to detect SARS-CoV-2 in saliva.
The CDC recently released guidance for clinicians and laboratory professionals on rapid antigen testing for SARS-CoV-2.
The Food and Drug Administration will host a webinar Aug. 18 at 12 p.m. ET on its umbrella emergency use authorization for certain disposable, single use surgical masks.
U.S. adults were more likely this June than a year ago to report adverse mental health conditions, substance use and suicidal ideation, according to a report released by the Centers for Disease Control and Prevention.
The Food and Drug Administration released FAQs describing the procedures for importing respirators, face masks, and other personal protective equipment or medical devices for which the agency has issued an emergency use authorization or enforcement discretion policy during the COVID-19 pandemic.
This AHA Special Bulletin provides details on the Department of Health and Human Services’ announcement that it has expanded the providers eligible for its Public Health and Social Services Emergency Fund “General Distribution.”
Thank you for your continued heroic work to care for your communities as our nation battles the COVID-19 pandemic. As you likely know, the Department of Health and Human Services (HHS) has requested that all hospitals report certain data on bed capacity, utilization, personal protective equipment (…
The Food and Drug Administration authorized the emergency use of George Washington University Public Health Laboratory’s GWU SARS-CoV-2 RT-PCR Test.
The Centers for Medicare & Medicaid Services announced the extension of its Appropriate Use Criteria testing period through 2021.
The Food and Drug Administration revoked its emergency use authorization for a SARS-CoV-2 antibody test made by Autobio Diagnostics Co. due to concerns with the accuracy of the test when evaluated at the National Institutes of Health’s Frederick National Laboratory for Cancer Research.